Evaluation of reduced susceptibility to vancomycin among mrsa strains isolated from clinical specimens;Kli̇ni̇k örneklerden i̇zole edi̇len mrsa suşlarinda vankomi̇si̇ne karşi azalmiş duyarliliǧin araştirilmasi

Mikrobiyoloji Bulteni

Volumn 44, Issue 2, 2010, Pages 339-341

  Aktaş, Elif ^a   Mengeloǧlu, Firat Zafer ^a   Külah, Canan ^a   Cömert, Füsun Beǧendik ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Heterogenous VISA; Methidllin resistant staphylococcus aureus; Vancomycin intermediate staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; VANCOMYCIN;

DRUG EFFECT; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; TURKEY (REPUBLIC);

ANTI-BACTERIAL AGENTS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TURKEY; VANCOMYCIN;

EID: 77952840902     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hageman JC, Patel JB, Carey RC, Tenover FC, McDonald LC. Investigation and control of vancomycin-in-termediate and -resistant Staphylococcus aureus: A Guide for Health Departments and Infection Control Personnel. Atlanta, GA 2006. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/visa-vrsa-guide.pdf.
2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth Informational Supplement. CLSI Document M100-S18, 2008. CLSI, Wayne, PA.
3. Appelbaum PC. Reduced glycopeptide susceptibility in methicillin- resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2007; 30: 398-408.
4. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32 (Suppl 2): S114-32.
5. Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003; 47: 3040-5.
6. Gemmell CG. Clycopeptide resistance in Staphylococcus aureus: is it a real threat? J Infect Chemother 2004; 10: 69-75.
7. Gülay Z, Atay T, Küçükgüven M, Yuluǧ N. Staphylococcus aureus strains heterogeneously resistant to vancomycin at a hospital in Turkey. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 24-27, 1998, San Diego, CA, USA. Programme and Abstracts, C-136.
8. Azap A, Ergin F, Kuru Inci E, Arslan H. Staphylococcus aureus suslarinda vankomisin direncinin arastirilmasi. Infeksiyon Derg 2003; 17: 289-91.
9. Çaǧatay A, Nakipoǧlu Y, Katranci H, Derbentli Ş. Istanbul Tip Fakültesi'nde çeşitli örneklerden izole edilen stafilokok suşlannda glikopeptit direncinin araştirilmasi. ANKEM 2004; 18: 209-12.
10. Ünaldi Ö, Güzel Ö, Engin D, et al. Nötropenik hastalarda vankomisine orta duyarli stafilokoklar. 19. ANKEM Klinikler ve Tip Bilimleri Kongresi. 30 Mayis-03 Haziran 2004, Side, Antalya. Bildiri No: 2.
11. Sancak B, Ercis S, Menemenlioglu D, Colakoglu S, Hascelik G. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 2005; 56: 519-23.
12. Torun MM, Bahar H, Demirci M, et al. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: brief report of a surveillance study. Int J Antimicrob Agents 2005; 26: 508-10.
13. Yilmaz M, Erdoǧan B, Sili U, et al. MRSA suşlarinda vankomisin intermediate Staphylococcus aureus (VISA) ve heterojen vankomisin intermediate Staphylococcus aureus (Hetero VISA) arajtinlmasi. 21. ANKEM Klinikler ve Tip Bilimleri Kongresi. 4-8 Haziran 2006, Kemer, Antalya. Poster No: 11.
14. Dizbay M, Sipahi AB, Günal Ö, et al. Metisiline dirençli Staphylococcus aureus izolatlarinda glikopeptid ve linezolid direncinin araştirilmasi. ANKEM 2007; 21: 23-6.
15. Hoşgör Umoncu M, Ermertcan S, Taşli H, Tünger Ö, Coşar G. Investigation of glycopeptide resistance in methicillin-resistant staphylococcal isolates. Mikrobiyol Bul 2007; 41: 511-6.